Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
10.19
-0.07 (-0.68%)
At close: May 7, 2026, 4:00 PM EDT
10.36
+0.17 (1.67%)
After-hours: May 7, 2026, 7:12 PM EDT
Arvinas Market Cap
Arvinas has a market cap or net worth of $651.76 million as of May 7, 2026. Its market cap has increased by 4.49% in one year.
Market Cap
651.76M
Enterprise Value
-24.74M
1-Year Change
4.49%
Ranking
Category
Stock Price
$10.19
Market Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $516.15M to $651.76M, an increase of 26.27%. That is a compound annual growth rate of 3.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 651.76M | -14.43% |
| Dec 31, 2025 | 761.70M | -42.17% |
| Dec 31, 2024 | 1.32B | -52.94% |
| Dec 29, 2023 | 2.80B | 53.71% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 6.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alpha Tau Medical | 690.88M |
| Tenax Therapeutics | 685.93M |
| Gyre Therapeutics | 685.75M |
| Aclaris Therapeutics | 678.77M |
| Sutro Biopharma | 659.90M |
| Cabaletta Bio | 652.20M |
| Zevra Therapeutics | 650.26M |
| Forte Biosciences | 640.59M |